Comparative outcomes between empagliflozin and dapagliflozin in heart failure: real world multi-center cohort study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Further Insights into SGLT2i treatment for heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by